Safety and Effectiveness of Pulmonary Vein isOLation And posterioR Wall Ablation wIth pulSed Field Energy in Patients With Paroxysmal and Persistent AF

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 442 participants.

Also called NCT06099730

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 442 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06099730
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06099730. Allocation not applicable; no masking; primary purpose treatment. Start 2023-12-14 (actual); primary completion 2028-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Effectiveness of Pulmonary Vein isOLation And posterioR Wall Ablation wIth pulSed Field Energy in Patients With Paroxysmal and Persistent AF
Acronym
POLARIS
Intervention (Device)
Pulsed Field Ablation (PFA)
Lead sponsor
Massachusetts General Hospital (class: other)

Record details

Record id
cardio:ct-nct06099730
Content hash
26a0685c9cc34f39f878f04290a59d89d0966da5fddaeadb3b8f3851fee8a9ea